Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Optimizing the success of cell transplantation therapy for stroke NEUROBIOLOGY OF DISEASE Bliss, T. M., Andres, R. H., Steinberg, G. K. 2010; 37 (2): 275-283

Abstract

Stem cell transplantation has evolved as a promising experimental treatment approach for stroke. In this review, we address the major hurdles for successful translation from basic research into clinical applications and discuss possible strategies to overcome these issues. We summarize the results from present pre-clinical and clinical studies and focus on specific areas of current controversy and research: (i) the therapeutic time window for cell transplantation; (ii) the selection of patients likely to benefit from such a therapy; (iii) the optimal route of cell delivery to the ischemic brain; (iv) the most suitable cell types and sources; (v) the potential mechanisms of functional recovery after cell transplantation; and (vi) the development of imaging techniques to monitor cell therapy.

View details for DOI 10.1016/j.nbd.2009.10.003

View details for Web of Science ID 000274224400006

View details for PubMedID 19822211

View details for PubMedCentralID PMC2818270